Vape stocks: Popular vape companies to invest in

Initially a popular stop-smoking aid, vaping has become popular in its own right in the UK. This article will give you the lowdown on the tech, where the industry’s headed, what the NHS and Public Health England think, and ways to invest in the sector. We’ll try not to make it a drag.

5 vape stocks to watch

We round up a selection of stocks in or related to the grain industry, weighting the list more heavily towards popular mid- and large-cap US stocks.

1. Turning Point Brands (TPB)
2. British American Tobacco (BATS)
3. Cronos Group (CRON)
4. Canopy Growth Corporation (CGC)
5. Altria Group (MO)

Vape stock	Icon	1-year performance (to Jun. '25)	5-year performance (to Jun. '25)	Link
Turning Point Brands (TPB)		129.02%	191.47%	Invest Capital at risk
British American Tobacco PLC (BATS)		50.08%	15.50%	Invest Capital at risk
Cronos Group (CRON)		-17.32%	-70.25%	Invest Capital at risk
Canopy Growth Corp (CGC)		-81.81%	-99.26%	Invest Capital at risk
Altria Group (MO)		32.79%	46.20%	Invest Capital at risk

How to invest in vape stocks

1. Choose a platform. If you’re a beginner, our share-dealing table below can help you choose.
2. Open your account. You’ll need your ID, bank details and national insurance number.
3. Confirm your payment details. You’ll need to fund your account with a bank transfer, debit card or credit card.
4. Search the platform for vape stock codes.
5. Research the shares you want to buy. The platform should provide the latest information available.
6. Buy your shares. It’s that simple.

Best for 0% commission stocks

Finder Award

Go to site

Capital at risk. T&Cs apply.

Copy picks from top traders

Commission-free trades
Fractional shares
Get dividend payments

Best for advanced trading

Go to site

Capital at risk. T&Cs apply.

Up to 4.25% interest on uninvested cash

11,000+ stocks & ETFs
Commission-free investing
Advanced trading tools

Best for overall trading platform

Go to site

Capital at risk. T&Cs apply.

Earn 4.5% on uninvested funds

Commission-free trades
Fractional shares
5,400+ stocks/ETFs

Take a deeper dive into vape stocks

If you're interested in investing in the vape industry, take a closer look at what companies in this industry do and how the stocks have historically performed. Keep in mind that positive past performance doesn't guarantee that a stock will continue to rise in the future.

Turning Point Brands (TPB)

Turning Point Brands, Inc. , together with its subsidiaries, manufactures, markets, and distributes branded consumer products in the United States and Canada. It operates through two segments, Zig-Zag Products and Stoker's Products. The Zig-Zag Products segment markets and distributes rolling papers, tubes, finished cigars, make-your-own cigar wraps, and related products, as well as lighters and other accessories under the Zig-Zag brand. The Stoker's Products segment manufactures and markets moist snuff tobacco and loose-leaf chewing tobacco products under the Stoker's, FRE, Beech-Nut, Durango, Trophy, and Wind River brands.

Turning Point Brands is listed on the NYSE, has a trailing 12-month revenue of around 384 million and employs 310 staff.

• Market capitalization: $1,351,525,504
• P/E ratio: 28.0669
• PEG ratio: 0.0503

Capital at risk

British American Tobacco (BATS)

British American Tobacco p. l. provides tobacco and nicotine products to consumers in the Americas, Europe, the Asia-Pacific, the Middle East, Africa, and the United States. It offers vapour, heated, and modern oral nicotine products; combustible cigarettes; and traditional oral products, such as snus and moist snuff. The company provides its products under the Vuse, glo, Velo, Grizzly, Kodiak, Dunhill, Kent, Lucky Strike, Pall Mall, Rothmans, Newport, Natural American Spirit, and Camel brands.

British American Tobacco is listed on the London Stock Exchange (LSE), has a trailing 12-month revenue of around $25.9 billion and employs 48,989 staff.

• Market capitalization: $78,558,896,128
• P/E ratio: 26.3824
• PEG ratio: 0.3986

Capital at risk

Cronos Group (CRON)

Cronos Group Inc. , a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. It offers dried flowers, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brand names. The company is based in Stayner, Canada.

Cronos Group is listed on the NASDAQ, has a trailing 12-month revenue of around £124.6 million and employs 459 staff.

• Market capitalization: $745,431,552
• P/E ratio: 13.7857

Capital at risk

Canopy Growth (CGC)

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis, hemp, and cannabis-related products in Canada, Germany, and Australia. It operates through four segments: Canada Cannabis, International Markets Cannabis, and Storz & Bickel, and This Works. The company offers dried flower and pre-rolled joints; extracts and concentrates, such as softgel capsules; cannabis edibles, including gummies; cannabis vapes; and oils, beverages, concentrates.

Canopy Growth is listed on the NASDAQ, has a trailing 12-month revenue of around $269 million and employs 960 staff.

• Market capitalization: $319,773,248

Capital at risk

Altria Group (MO)

Altria Group, Inc. , through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States. The company offers cigarettes primarily under the Marlboro brand; large cigars and pipe tobacco under the Black & Mild brand; moist smokeless tobacco and oral tobacco products under the Copenhagen, Skoal, Red Seal, and Husky brands; oral nicotine pouches under the on! brand; and e-vapor products under the NJOY ACE brand. It sells its products to distributors, as well as large retail organizations, such as chain stores.

Altria Group is listed on the NYSE, has a trailing 12-month revenue of around $20.2 billion and employs 14,654 staff.

• Market capitalization: $100,746,960,896
• P/E ratio: 10.0352
• PEG ratio: 4.0147

Capital at risk

Bottom line

Vape stocks are susceptible to market fluctuations and regulatory changes within the vaping industry. Vaping has gained popularity as a smoking cessation aid, with e-cigarettes considered safer alternatives by the NHS and Public Health England. However, vaping is drawing regulatory scrutiny globally, leading to restrictions and bans in some countries. Major tobacco companies like British American Tobacco and Altria have made strategic moves into the vaping market, acquiring vape store chains and launching their own product lines.

Investing in vape stocks means exposure to both vaping and other business activities, as there are no “pure play” options. Regulatory risks must be considered, as vaping faces concerns over its potential as a gateway to smoking.

On the plus side, the sector is forecast to experience tremendous growth over this decade, with one estimate as high as 30.6% CAGR from 2023 to 2030.

Frequently asked questions

• What are the regulatory risks of investing in vape stocks?

  For now, Public Health England says that e-cigarettes are 95% safer than smoking.

  However, vaping is increasingly drawing scrutiny from regulators around the world, particularly over claims that it could be a gateway drug for youngsters to end up hooked on cigarettes.

  Publicly traded companies that sell e-cigarettes, e-liquids and other vaping paraphernalia could find their business activities curtailed in some jurisdictions. The regulatory environment is evolving rapidly, with some countries – like Brazil, Singapore and India – having banned the sale of the electronic devices altogether.

• Are there any pure play vape stocks?

  No. All the companies mentioned produce vaping products while also being involved in other business activities.

  That means investing in these stocks exposes you to sectors you might not be interested in, like regular cigarettes in the case of BTI and Altri Group or cannabinoid products in the examples of Cronos Group and Canopy Growth Corporation.

• Is the vaping sector growing fast?

  In 2022, the US had 44% of the global revenue share of the e-cigarette and vape market, according to Grand View Research, a market research agency.

  The same agency estimates the global vaping market will grow by a massive 30.6% compound annual growth rate (CAGR) from 2023 to the end of the decade.